Calderone R A, Cihlar R L, Lee D D, Hoberg K, Scheld W M
J Infect Dis. 1985 Oct;152(4):710-5. doi: 10.1093/infdis/152.4.710.
Two spontaneous cerulenin-resistant mutants of Candida albicans, 4918-2 and 4918-10, were unable to adhere in vitro in fibrin-platelet clots. Because in vitro adherence correlates well with colonization of nonbacterial thrombotic endocarditis on traumatized valvular endocardium, 50% infectious dose studies were performed with a rabbit model of endocarditis. Wild-type C. albicans required 10(3.6) +/- 0.12 cfu in comparison with 10(5.73) +/- 0.31 and 10(7.3) +/- 0.21 cfu for mutants 4918-2 and 4918-10, respectively. The relative avirulence of mutant strains in producing endocarditis was not attributed to accelerated clearance of these strains from the bloodstream. In fact, clearance of wild-type and mutant strains was almost identical. In the same animals renal candidiasis was observed with all strains of C. albicans, although the number of cfu per gram of kidney was higher after infection with wild-type C. albicans. Thus, strains of C. albicans with reduced ability to adhere in vitro to a fibrin-platelet matrix are relatively avirulent in the rabbit endocarditis model.
白色念珠菌的两个自发的抗浅蓝菌素突变体4918 - 2和4918 - 10在体外无法黏附于纤维蛋白 - 血小板凝块。由于体外黏附与创伤性瓣膜心内膜上非细菌性血栓性心内膜炎的定植密切相关,因此用兔心内膜炎模型进行了50%感染剂量研究。野生型白色念珠菌需要10(3.6)±0.12 cfu,而突变体4918 - 2和4918 - 10分别需要10(5.73)±0.31和10(7.3)±0.21 cfu。突变菌株在引起心内膜炎方面相对无毒力并非归因于这些菌株从血流中的加速清除。事实上,野生型和突变菌株的清除情况几乎相同。在相同的动物中,所有白色念珠菌菌株都观察到肾念珠菌病,尽管感染野生型白色念珠菌后每克肾脏中的cfu数量更高。因此,在兔心内膜炎模型中,体外黏附于纤维蛋白 - 血小板基质能力降低的白色念珠菌菌株相对无毒力。